Skip to main content
. 2017 Jun 8;1(5):406–420. doi: 10.1002/hep4.1052

Table 3.

DEMOGRAPHICS AND PREOPERATIVE CHARACTERISTICS OF RECIPIENTS CORRELATED WITH RS2232365 GENOTYPE

Variables A/A (n = 85) A/G+G/G (n = 17) P Valuea
Gender 0.05
Male 56 (65.88) 7 (41.18)
Female 29 (34.12) 10 (58.82)
Age (year) 53.12 ± 11.09 55.05 ± 10.07 0.71
ABO Compatibility 0.22
Compatible 70 (82.35) 16 (94.12)
Incompatible 15 (17.65) 1 (5.88)
Original disease 0.74
HCV 29 (34.12) 8 (47.06)
HBV 18 (21.18) 3 (17.65)
Autoimmune disease 10 (11.76) 1 (5.88)
Others 28 (32.94) 5 (29.41)
MELD 18.08 ± 8.68 18.70 ± 7.94 0.47
Child‐Turcotte‐Pugh 0.61
A 6 (7.06) 2 (11.76)
B 30 (34.12) 4 (23.53)
C 50 (58.82) 11 (64.71)
Donor 0.74
Parent 5 (5.88) 1 (5.88)
Child 47 (55.29) 12 (70.59)
Sibling 13 (15.29) 1 (5.88)
Spouse 18 (21.18) 3 (17.65)
Others 2 (2.35) 0 (0)
HLA total mismatches 3.49 ± 1.60 3.58 ± 1.41 0.97
HLA Class I mismatches 2.41 ± 1.06 2.41 ± 1.06 0.90
HLA Class II mismatch 1.13 ± 0.69 1.17 ± 0.63 0.84
GRWR 0.90 ± 0.21 0.85 ± 0.17 0.26

GRWR, graft‐to‐recipient weight ratio; HBV, hepatitis B virus; HCV, hepatitis C virus; LDLT, Living donor liver transplantation; MELD, model for end‐stage liver disease; SD, standard deviation

Categorical variables are presented as number (%), while continuous variables are presented as mean ± SD.

a

Pearson's chi‐squared test/ Wilcoxon rank sum tests, a difference was considered significant if P‐value was < 0.05.

Typed HLA antigens: HLA‐A1, HLA‐A2, HLA‐B1, HLA‐B2, HLA‐DR1, and HLA‐DR2.